VIM and cancer: Additionally, HBECs treated by highly metastatic cell-derived exosomes and late stage cancer serum-derived exosomes had higher VIM expression compared to HBECs treated by nonmetastatic cell-derived exosomes and healthy serum-derived exosomes, respectively.